ALEXANDRA SCHAEFFER: Open Payments
NPI 1265073365 · WEST LAWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,927 in 130 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $855 · 2025 $2,927
Food & beverage: $2,633Education: $294
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $576 |
| ABBVIE INC. | 26 | $415 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $250 |
| UCB, Inc. | 11 | $231 |
| Novartis Pharmaceuticals Corporation | 8 | $181 |
| Galderma Laboratories, L.P. | 15 | $178 |
| E.R. Squibb & Sons, L.L.C. | 5 | $159 |
| Lilly USA, LLC | 10 | $138 |
| GENZYME CORPORATION | 4 | $126 |
| LEO Pharma Inc. | 5 | $118 |
Products named: DUPIXENT, SKYRIZI, Bimzelx, Sotyktu, NEMLUVIO, OTEZLA, TALTZ, COSENTYX.
Industry payments across PA — which companies pay providers there.
